Omalizumab facilitates rapid oral desensitization for peanut allergy
@article{MacGinnitie2017OmalizumabFR, title={Omalizumab facilitates rapid oral desensitization for peanut allergy}, author={Andrew MacGinnitie and R. Rachid and Hana Gragg and S. Little and Paul R Lakin and A. Cianferoni and J. Heimall and M. Makhija and R. Robison and S. Chinthrajah and John J Lee and Jennifer S LeBovidge and T. Dominguez and C. Rooney and M. O. Lewis and J. Koss and Elizabeth Burke-Roberts and K. Chin and T. Logvinenko and J. Pongracic and D. Umetsu and J. Spergel and K. Nadeau and L. Schneider}, journal={The Journal of Allergy and Clinical Immunology}, year={2017}, volume={139}, pages={873–881.e8} }
Background: Peanut oral immunotherapy is a promising approach to peanut allergy, but reactions are frequent, and some patients cannot be desensitized. The anti‐IgE medication omalizumab (Xolair; Genentech, South San Francisco, Calif) might allow more rapid peanut updosing and decrease reactions. Objective: We sought to evaluate whether omalizumab facilitated rapid peanut desensitization in highly allergic patients. Methods: Thirty‐seven subjects were randomized to omalizumab (n = 29) or placebo… CONTINUE READING
Figures, Tables, and Topics from this paper
Paper Mentions
126 Citations
Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab.
- Medicine
- The journal of allergy and clinical immunology. In practice
- 2019
- 12
Comparison of sublingual immunotherapy and oral immunotherapy in peanut allergy
- Medicine
- Allergo Journal International
- 2018
- 3
Immunotherapy for Food Allergy: Are We There Yet?
- Medicine
- The journal of allergy and clinical immunology. In practice
- 2017
- 62
- Highly Influenced
Is epicutaneous immunotherapy only skin deep?
- Medicine
- The Journal of allergy and clinical immunology
- 2017
- 3
- Highly Influenced
References
SHOWING 1-10 OF 51 REFERENCES
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
- Medicine
- The Journal of allergy and clinical immunology
- 2013
- 198
- PDF
Oral peanut immunotherapy in children with peanut anaphylaxis.
- Medicine
- The Journal of allergy and clinical immunology
- 2010
- 348
Modified peanut oral immunotherapy protocol safely and effectively induces desensitization.
- Medicine
- The journal of allergy and clinical immunology. In practice
- 2015
- 22
Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy.
- Medicine
- The Journal of allergy and clinical immunology
- 2011
- 272
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison.
- Medicine
- The Journal of allergy and clinical immunology
- 2013
- 87
A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.
- Medicine
- The Journal of allergy and clinical immunology
- 2011
- 429
- Highly Influential
Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial
- Medicine
- The Lancet
- 2014
- 279
- Highly Influential
Clinical efficacy and immune regulation with peanut oral immunotherapy.
- Medicine
- The Journal of allergy and clinical immunology
- 2009
- 598
Egg oral immunotherapy in nonanaphylactic children with egg allergy.
- Medicine
- The Journal of allergy and clinical immunology
- 2007
- 362
- Highly Influential
Effect of anti-IgE therapy in patients with peanut allergy.
- Medicine
- The New England journal of medicine
- 2003
- 591
- PDF